Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Frontline Plc Ordinary Shares (FRO) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance

Frontline Plc Ordinary SharesTrade
Halozyme Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Frontline Plc Ordinary Shares vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Frontline Plc Ordinary Shares trades at $56.26 (market cap $12.52B), while Halozyme Therapeutics Inc. Common Stock trades at $111.18 (market cap $12.58B). The key difference: Frontline Plc Ordinary Shares and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Frontline Plc Ordinary Shares pays a 9.56% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Frontline Plc Ordinary Shares for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.

FROHALO
Market Cap
$12.52B$12.58B
Volume
6,375,5092,179,278
Sector
IndustrialsHealth
52-Week High
$56.26$115.22
52-Week Low
$20.58$61.63
Typical Hold Time
0 Days0 Days
Enterprise Value
$14.64B$14.49B
Dividend Yield
9.56%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FRO
77% Buy23% Sell
Avg holding period · 0 Days
HALO
100% Buy0% Sell
Avg holding period · 0 Days

About Frontline Plc Ordinary Shares

Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.

Read more on FRO →

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →